Skip navigation
Merrion pharmaceuticals - making medicines better
Skip navigation

Analyst Coverage

The equity/research analysts at the firms listed below currently write research reports on Merrion Pharmaceuticals plc. Please note that this list is subject to change and that any estimates, forecasts or opinions are made by the analysts alone and do not represent the estimates, forecasts or opinions of Merrion. Merrion does not by its reference below imply its endorsement of or concurrence with such information, conclusions or recommendations. Reports issued may have become out of date after publication and should be read accordingly. Unless otherwise indicated, the research cannot be obtained from Merrion but investors may contact analyst directly in order to obtain copies of a research note.

Jack Gorman
Davy Stockbroker

John Savin  
Edison Investment Research
Investment Summary: Project Diversification
Edison Research 28/02/2011
  Investment Summary: Switch to breast cancer
Edison Research 19/11/2010
  Investment Summary: Imminent deals
Edison Research 11/03/2010
Investment Summary: Oral insulin goes clinical
Edison Research 11/12/2009
  Investment Summary: Raising its profile
Edison Research 05/11/2009
  Investment Summary: Nil by needle
Edison Research 14/09/2009